The Cactus Life Sciences team contributes to the publishing industry’s understanding of medical communications by conducting research and putting forth opinion on key industry challenges and areas of interest.

These research works and opinion pieces may be presented as posters at industry conferences or published in relevant industry journals. The following are two journal publications authored by members of our team

  1. Res Integr Peer Rev. 2019 Oct 2;4:21. doi: 10.1186/s41073–019–0079–1. eCollection 2019.

A guide to applying the Good Publication Practice 3 guidelines in the Asia-Pacific region

This commentary focuses on how well industry standards like the Good Publication Practice 3 (GPP3) guidelines and the International Committee of Medical Journal Editors (ICMJE) criteria for authorship are understood and applied in the Asia Pacific region. The authors discuss potential barriers to compliance with these guidelines and make suggestions for better uptake and compliance.

2. JAMA Intern Med. 2015 Sep;175(9):1587. doi: 10.1001/jamainternmed.2015.3229.

A Potential Solution for Research Misconduct

In this Letter to the Editor, the authors respond to a previously published article on research misconduct identified by the US FDA, proposing that there be a regulatory requirement that all forms of clinical trial data communications—from the database through all presentations and publications (including
the product-prescribing information document [PID])—should contain identifiers.

Share this post

About the author

Cactus Life Sciences
+ posts

Cactus Life Sciences helps pharma, biotech, and medical device organizations worldwide with content strategy, development, and data. We work with medical affairs to disseminate insight-driven information to healthcare professionals, payors, and patients in a range of formats.